L
Lisata Therapeutics, Inc. (LSTA)
NCM – Real Time Price. Currency in USD
3.36
-0.02 (-0.59%)
At close: Jun 26, 2026, 4:00 PM EDT
3.36
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
3.36
-0.02 (-0.59%)
At close: Jun 26, 2026, 4:00 PM EDT
3.36
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:10 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 4.23 | 6.05 | 10 | |
| Quick ratio | 4.23 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | 1M | 170K | 170K |
| Gross Profit | -69K | -189K | 826K | 24K | 65K |
| Operating Income | -27M | -26M | -22M | -18M | -17M |
| Net Income | -54M | -21M | -20M | -17M | -16M |
| EBITDA | -27M | -26M | -22M | -18M | -17M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | -100 | 54.58 | 5.5 |
| Next year | N/A | -6.42 | 1.0 |
| Weighted average score | 2.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -99.99 | -51.95 | N/A | 5.11 | 2.0 |
| Y/Y | 999 | 4.97 | N/A | 42.93 | 6.3 |
| 3y average | 638.34 | 27.56 | 27.45 | 9.15 | 9.0 |
| 5y average | 782.6 | -50.34 | 9.68 | -24.18 | 4.5 |
| Weighted average score | 5.5 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Cash reserves $13.1M barely cover the upcoming debt maturities $0.0
Total current assets $14.0M exceed Total current liabilities $3.3M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$3.1M limits the company's ability to reinvest or pay down debt